GSK-104567



Phase IIIb, multicentre study to assess safety & immunogenicity of GSK Biologicals’ combined DTPa/Hib (Infanrix/Hib) vaccine vs separate administration of DTPa (Infanrix) & Hib (Hiberix) vaccines in healthy infants 3,4,&5 months of age as compared with the separate administration of DTPa and Hib vaccines at different injection sites.
Diphtheria, Tetanus, Acellular Pertussis Vaccine Adsorbed
104567
NCT00412854
Acellular pertussis; Diphtheria; Tetanus
Phase 3
 
May 2013